Best Buy's decision to sell prescription-based medical devices, starting with the Dexcom G7 Continuous Glucose Monitoring System, could potentially open up a new revenue stream for the company. This move is in line with the company's goal to facilitate care at home, which could be a growing market given the increasing prevalence of conditions like diabetes. The positive price action on Friday suggests that the market is reacting favorably to this news.